Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydrocodone (oxycodone) vs sufentanil PCIA after OPCABG
ChiCTR2400092444Phase 4Not yet recruiting
- Sponsor
- Yidu Central Hospital of Weifang City
- Start
- Nov 2024
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in coronary arteriosclerosis and postoperative pain comparing Oxycodone PCIA arm with Sufentanil PCIA arm (2 arms). Primary endpoint: Incidence of moderate to severe pain within 72 hours after surgery. Planned start Nov 2024; status: not yet recruiting.
02
Drugs
oxycodonesufentanil
03
Conditions
coronary arteriosclerosispostoperative pain
Beyond the preview
Go deeper on ChiCTR2400092444.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400092444.